Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-2,709 Cr₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹-2,709 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-2,709 Cr
Mar2025₹787 Cr
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-2,709 Cr
Negative
Mar2025 ₹787 Cr
Positive
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹68,489.9 Cr -2.5% 5.6% 27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.5%

5.6%

27.5%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses